Chugai posts transcript of FY2026 Q2 financial results conference callPUBT·Jul 27 at 03:54 AMCHGCY-2.44%4519
Chugai Pharmaceutical (TSE:4519) Stock Net Margin Strength Challenges Cost Pressure ConcernsSimplywall·Jul 26 at 12:13 PM4519
Chugai Pharma FY26 Q2 net income climbs 19.2% to ¥231.7 billion; revenue rises 14.7% to ¥663.3 billionPUBT·Jul 24 at 02:06 AM4519
Chugai Pharmaceutical : Double-digit revenue and profit growth driven by strong sales and robust pipeline progressQuartr·Jul 24 at 02:01 AMCHGCY-2.44%4519
Rani Therapeutics Maintained at Buy as Partnerships Highlight Underappreciated Pipeline; $11 Price Target ReaffirmedTip Ranks·Jul 13 at 10:35 AMRANI-5.63%4519
Sobi tops bleeding disorder patient groups' reputation rankingsFiercepharma·Jul 10 at 03:17 AMNVO-8.78%RHHBY-1.09%
Chugai Pharma Taiwan Wins Asia Responsible Enterprise Awards for Fifth Consecutive YearTaipei Times·Jun 30 at 11:12 AM4519
3 Japanese Large Caps Trading Below Fair Value on Cash Flow EstimatesSimplywall·Jun 30 at 10:58 AM69764680
Undervalued Cash Flow Stocks With High ROE Investors May Be MissingSimplywall·Jun 18 at 05:54 PM45193064
MonotaRO Stock And Two High Quality Undervalued Compounders To WatchSimplywall·Jun 16 at 10:09 PM45193064
